Get startedLog in
    Picture of JW (Cayman) Therapeutics Co logo

    2126 — JW (Cayman) Therapeutics Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    All News

    Brief: JW (Cayman) Therapeutics Received Investigational New Drug Clearance From NMPA Of China For Clinical Trials

    Picture of JW (Cayman) Therapeutics Co logoJW (Cayman) Therapeutics Co
    27/09/2021 11:18
    Sept 27 (Reuters) - JW (Cayman) Therapeutics Co Ltd
 2126.HK :
    * RECEIVED INVESTIGATIONAL NEW DRUG CLEARANCE FROM NMPA OF
CHINA
FOR CLINICAL TRIALS IN TREATING MYELOMA
    * GOT CLEARANCE FOR CLINICAL TRIALS OF B CELL MATURATION
ANTIGEN
TARGETED CHIMERIC ANTIGEN RECEPTOR T CELL (JWCAR129)

Source text for Eikon:  ID: 
Further company coverage:  2126.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on JW (Cayman) Therapeutics Co

    See all news